Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.
Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.
复制标题
DOI:
10.1021/jm100786g
复制
发表时间:
2010-12-23
影响因子:
7.3
通讯作者:
Shim H
中科院分区:
文献类型:
--
作者:
Zhu A;Zhan W;Liang Z;Yoon Y;Yang H;Grossniklaus HE;Xu J;Rojas M;Lockwood M;Snyder JP;Liotta DC;Shim H
The C-X-C chemokine receptor type 4 (CXCR4)/stromal cell derived factor-1 (SDF-1 or CXCL12) interaction and the resulting cell signaling cascade play a key role in metastasis and inflammation. Based on the previously published CXCR4 antagonist 5 (WZ811), a series of novel non-peptidic anti-CXCR4 small molecules have been designed and synthesized to improve potency. Following a structure-activity profile around 5, more advanced compounds in the N, N'-(1, 4-phenylenebis(methylene)) dipyrimidin-2-amines series were discovered and shown to possess higher CXCR4 binding potential and specificity than 5. Compound 26 (508MCl) is the leading compound, and exhibits subnanomolar potency in three in vitro assays including competitive binding, Matrigel invasion, and Gαi cyclic adenosine monophosphate (cAMP) modulation signaling. Furthermore, compound 26 displays promising effects by interfering with CXCR4 function in three mouse models: paw inflammation, Matrigel plug angiogenesis, and uveal melanoma micrometastasis. These data demonstrate that dipyrimidine amines are unique CXCR4 antagonists with high potency and specificity.
登录
查看更多内容
影响因子:
56.9
作者:
Feng, Y;Broder, CC;Berger, EA
通讯作者:
Berger, EA
影响因子:
120.1
作者:
De Clercq, E
通讯作者:
De Clercq, E
影响因子:
4.4
作者:
Gupta, SK;Pillarisetti, K;Aiyar, N
通讯作者:
Aiyar, N
影响因子:
3.6
作者:
Kajiyama, Hiroaki;Shibata, Kiyosumi;Kikkawa, Fumitaka
通讯作者:
Kikkawa, Fumitaka
影响因子:
0.9
作者:
Gao, C.;Li, Y.
通讯作者:
Li, Y.